Humana Inc. (NYSE:HUM) Shares Acquired by Ossiam

Ossiam grew its stake in Humana Inc. (NYSE:HUM) by 187.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,297 shares of the insurance provider’s stock after acquiring an additional 8,667 shares during the quarter. Ossiam’s holdings in Humana were worth $5,663,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of HUM. E Fund Management Co. Ltd. acquired a new stake in shares of Humana in the 1st quarter worth $195,000. Quilter Plc purchased a new position in shares of Humana during the 1st quarter worth $263,000. Prudential Financial Inc. grew its holdings in shares of Humana by 25.5% during the 1st quarter. Prudential Financial Inc. now owns 157,459 shares of the insurance provider’s stock worth $66,014,000 after purchasing an additional 32,029 shares during the period. Moors & Cabot Inc. boosted its holdings in Humana by 11.4% during the 1st quarter. Moors & Cabot Inc. now owns 1,431 shares of the insurance provider’s stock valued at $600,000 after acquiring an additional 147 shares during the period. Finally, Cresset Asset Management LLC boosted its holdings in Humana by 82.1% during the 1st quarter. Cresset Asset Management LLC now owns 1,704 shares of the insurance provider’s stock valued at $716,000 after acquiring an additional 768 shares during the period. 91.85% of the stock is owned by institutional investors and hedge funds.

In other Humana news, Director David A. Jr/Ky Jones sold 4,800 shares of Humana stock in a transaction that occurred on Thursday, September 16th. The stock was sold at an average price of $401.00, for a total transaction of $1,924,800.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.40% of the company’s stock.

HUM has been the subject of a number of research analyst reports. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $490.00 target price for the company in a report on Friday, July 16th. JPMorgan Chase & Co. raised their target price on Humana from $440.00 to $514.00 and gave the company an “overweight” rating in a report on Friday, July 9th. Cowen started coverage on Humana in a report on Thursday, September 9th. They set an “outperform” rating and a $479.00 target price for the company. SVB Leerink started coverage on Humana in a research note on Monday, September 27th. They issued an “outperform” rating and a $494.00 price objective for the company. Finally, Barclays started coverage on Humana in a research note on Thursday, September 9th. They issued an “overweight” rating and a $500.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $486.92.

Shares of NYSE HUM traded up $13.27 during midday trading on Thursday, hitting $433.96. 10,808 shares of the company’s stock were exchanged, compared to its average volume of 896,439. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.71 and a quick ratio of 1.71. Humana Inc. has a twelve month low of $370.22 and a twelve month high of $475.44. The company has a market cap of $55.77 billion, a PE ratio of 22.24, a P/E/G ratio of 1.42 and a beta of 0.89. The firm’s fifty day simple moving average is $406.80 and its 200-day simple moving average is $428.72.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 28th. The insurance provider reported $6.89 earnings per share for the quarter, topping the consensus estimate of $6.86 by $0.03. Humana had a return on equity of 13.62% and a net margin of 3.09%. The business had revenue of $20.65 billion for the quarter, compared to analyst estimates of $20.51 billion. Equities analysts anticipate that Humana Inc. will post 21.49 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 29th. Shareholders of record on Thursday, September 30th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Wednesday, September 29th. Humana’s dividend payout ratio (DPR) is 14.93%.

About Humana

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts.

Featured Story: What is the accumulation/distribution indicator?

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.